June 9, 2014

The National Association of Chain Drug Stores announced on Monday the creation of “Vision 2025” to provide attendees with a glimpse of “what comes next” in the industry through technology platforms, displays and interactive experiences.

June 3, 2014

Asana BioSciences, a research and development company specializing in the discovery and development of new chemical and biological entities, on Tuesday announced that it has acquired an early stage branded pharmaceutical discovery platform from Endo Pharmaceuticals.

June 3, 2014

HDMA on Tuesday honored pharmaceutical and consumer product manufacturers at its 2014 Business and Leadership Conference in Phoenix, through the presentation of the Association’s annual Distribution Industry Awards for Notable Achievements in Healthcare (the DIANA awards).

June 2, 2014

Greenstone on Tuesday announced the introduction of nadolol tablets to its generic pharmaceutical product line. The drug is available in dosage strengths of 20-mg x 100, 40-mg x 100 and 80-mg x 100.

May 29, 2014

Gov. Alejandro García Padilla on Wednesday announced an agreement by Puerto Rico Industrial Development Co. with Actavis that will allow the pharmaceutical manufacturer to develop a solid dosage manufacturing and packing facility in its Manati site and expand its current hormone production in Fajardo.

May 22, 2014

More than 10 million Hispanics are eligible to gain health insurance coverage under the Affordable Care Act, representing unparalleled opportunity for businesses aiming to succeed in the emerging health economy focused on delivering consumer-centered care, according to "Hispanics: A growing force in the New Health Economy," a new report from PwC's Health Research Institute.

May 21, 2014

Practice Fusion on Wednesday launched its real-time healthcare database, Insight. With Insight, physicians, researchers and analysts can access analysis sourced from a de-identified subset of more than 81 million patient records.

May 16, 2014

Abbott announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence the company reported.

May 15, 2014

Greenstone announced the introduction of rifabutin capsules to its product line. The drug is the authorized generic version of Mycobutin.

May 15, 2014

On May 5 to 9, Armada Health Care hosted its 10th Annual Specialty Pharmacy Summit at the Wynn Hotel in Las Vegas, Nevada.

May 15, 2014

The stampede of big-selling branded medicines that hurtled off the patent cliff in 2011 and 2012 has slowed to a relative trickle.

May 14, 2014

Actavis on Wednesday announced the proposed senior management team that will lead the specialty pharmaceutical company pending the successful close of the acquisition of Forest Labs, which is anticipated at mid-year.

May 13, 2014

McKesson reported that revenues for the fourth quarter ended March 31 were $38.1 billion, up 25%.

May 12, 2014

DSN had the opportunity to sit down and talk with Doug Hebert, Co-Founder and Vice President of RxArmory, and Shelly Mowrey, Vice President of RxArmory about the importance of substance abuse prevention.

May 9, 2014

A panel of speakers from all facets of health care convened yesterday to discuss the growth of the specialty pharmaceuticals industry during the 10th Annual Specialty Pharmacy Summit & Expo, hosted by Armada Health Care.

May 9, 2014

Bayer agreed to acquire the consumer care business of U.S. pharmaceutical company Merck for a purchase price of $14.2 billion. The OTC acquisition will give Bayer the global No. 2 position in nonprescription products following recently announced consolidations in this growing healthcare industry segment, and will significantly enhance Bayer’s business across multiple therapeutic categories and geographies. Merck's consumer care business includes such leading brands as Claritin, Coppertone and Dr. Scholl’s. Pro forma sales of the combined businesses in 2013 amounted to $7.4 billion with Merck’s business contributing approximately $2.2 billion.

Upon completion of the acquisition, Bayer is expected to achieve global leadership positions in dermatology and gastrointestinals and advance to the No. 2 position in the cold, allergy, sinus and flu category. Bayer will remain No. 2 in nutritionals and No. 3 in analgesics. Overall, the proposed GlaxoSmithKline-Novartis combination represents the largest consumer health business with about 5.7% share, according to reports. The Bayer/Merck combination comes in second with around 4.5% share. McNeil Consumer rounds out the top three globally with a share just above 4%.

May 7, 2014

Symphony Health Solutions last week announced it now offers weekly views of pharmaceutical sales and prescription activity.

May 6, 2014

Bayer on Tuesday agreed to acquire the consumer care business of U.S. pharmaceutical company Merck for a purchase price of $14.2 billion.

April 29, 2014

Endo International on Tuesday announced that it will acquire Somar, a privately-owned specialty pharmaceuticals company based in Mexico City, Mexico.

April 28, 2014

As lifetime earnings for pharmaceuticals decrease, commercialization expenses increase and payers tighten their belts on reimbursement, life science companies will be faced with shrinking margins over the next few years.

April 28, 2014

U.S. pharmaceutical firm Pfizer this morning confirmed discussions with AstraZeneca regarding a possible merger. If the transaction goes through, it's expected that the two companies will combine under a new U.K-incorporated holding company.

April 25, 2014

The Generic Pharmaceutical Association has announced its support of the U.S. Drug Enforcement Administration’s eighth annual National Prescription Drug Take-Back Day, taking place April 26 at local take-back sites across America.

April 24, 2014

Armada Health Care, a provider for channel management solutions, commercialization strategies, and support services for the specialty pharmaceutical industry, has announced the launch of a new specialty pharmacy software solution called Vision Armada Analytics.

April 21, 2014

Lupin on Monday announced the appointment of Theresa Stevens as chief corporate development officer for its global operations.